Results 171 to 180 of about 2,529 (191)
Some of the next articles are maybe not open access.

Vibration Response for class D44 and D39 200 Locomotive Wheelsets due to Dynamic Loads Excitation

2019 Open Innovations (OI), 2019
Wheelset vibration response of two Transnet locomotive classes i.e. D39 200 and D44 are investigated using the modal analysis method. These two locomotive classes are the only classes used on the Belfast to Steelpoort railway line in the Limpopo Province of South Africa. The class D44 replaced the class D39 200 locomotives over two years ago.
Bingo Balekwa, Daramy Vandi Von Kallon
exaly   +2 more sources

Isoforms of the E2 molecule: D44 monoclonal antibody defines an epitope on E2 and reacts differentially with T cell subsets

European Journal of Immunology, 1991
AbstractHuman T cell rosetting with erythrocytes is clearly dependent on the CD2‐CD58 interaction. We have previously demonstrated that other T cell molecules are involved in the rosette phenomenon, including the E2 molecule, a 32‐kDa transmembrane glycoprotein.
C Gelin   +2 more
exaly   +3 more sources

Regulation of immunoglobulin synthesis by human T cell subsets as defined by anti-D44 monoclonal antibody within the CD4+ and CD8+ subpopulations.

Journal of Immunology, 1986
Abstract In our previous paper, we demonstrated that anti-D44 MAb can, in the presence of complement, eliminate all the allocytotoxicity generated during a mixed lymphocyte reaction without affecting the alloproliferative response. As approximately 70% of CD4+ cells and 30% of CD8+ will be stained with anti-D44 MAb, we researched the ...
S Huet, Eric Leroy, L Boumsell
exaly   +3 more sources

A novel human leukocyte differentiation antigen: monoclonal antibody anti-D44 defines a 28 Kd molecule present on immature hematologic cells and a subpopulation of mature T cells.

Journal of Immunology, 1984
Abstract Anti-D44 is a cytotoxic IgG2b monoclonal antibody (MAb), which reacts with two polypeptides of 28 and 30 Kd from human peripheral T cells after western blotting. The antigen is present in low density on bone marrow cells from the myeloid lineage, probably including most CFU-GM; the antigen is present on megakaryocytes but is not
M Amiot, B Caillou, Pierre Charbord
exaly   +3 more sources

Preferential elimination of NK and CTL functions by anti-D44 monoclonal antibody.

The Journal of Immunology, 1984
Abstract Monoclonal antibodies reactive with T cells at various stages of maturation were used in negative selection experiments to study their effects on NK function in the presence of complement. Anti-D47 and anti-A50, respectively, directed against corticothymocytes and mature peripheral E+ cells were without effect. Anti-D66 reactive
C F, Calvo   +5 more
openaire   +2 more sources

MPEC 2023-D44 : S/2022 J 1

2023
The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

Pimarane Diterpene and Cytochalasin Derivatives from the Endophytic Fungus Eutypella scoparia PSU-D44

Journal of Natural Products, 2006
Two pimarane diterpenes, named scopararanes A (1) and B (2), and two cytochalasins, named scoparasins A (3) and B (4), along with 4,8-dihydroxy-6-methoxy-4,5-dimethyl-3-methyleneisochroman-1-one (5) and diaportheins A (6) and B (7) were isolated from a culture broth of the endophytic fungus Eutypella scoparia PSU-D44.
Wipapan, Pongcharoen   +4 more
openaire   +2 more sources

MPEC 2024-D44 : 2024 DF

The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

Home - About - Disclaimer - Privacy